Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial

Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new note indicating 2016 U.S. NIH Grant/Contract funding was added. The page's revision label was updated to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T20:03:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision marker was updated from v3.6.4 to v3.6.5. This indicates a new build of the ClinicalTrials.gov page, typically reflecting minor updates or fixes rather than changes to study data.
    Difference
    0.0%
    Check dated 2026-08-08T18:18:08.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a backend or documentation update. The change reflects an internal update to the study record rather than modifications to visible study details.
    Difference
    0.0%
    Check dated 2026-07-25T11:35:29.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page shows a revised version label, updating the revision from v3.6.2 to v3.6.3. This indicates a minor site update rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-07-04T04:12:39.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision indicator updated from v3.6.0 to v3.6.2, signaling a small site update rather than a change to the study information.
    Difference
    0.0%
    Check dated 2026-06-27T01:48:14.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now includes a new line stating 'No longer looking for participants', indicating that recruitment for the study has ended. This informs readers that enrollment is closed and no new participants can join.
    Difference
    0.4%
    Check dated 2026-06-12T16:39:46.000Z thumbnail image

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.